Abstract:Predicting drug–disease associations can contribute to discovering new therapeutic potentials of drugs, and providing important association information for new drug research and development. Many existing drug–disease association prediction methods have not distinguished relevant background information for the same drug targeted to different diseases. Therefore, this paper proposes a drug–disease association prediction model based on graph convolutional network and graph attention network (GCNGAT) to reposition marketed drugs under the distinguishment of background information. Firstly, in order to obtain initial drug–disease information, a drug–disease heterogeneous graph structure is constructed based on all known drug–disease associations. Secondly, based on the heterogeneous graph structure, the corresponding subgraphs of each group of drug–disease association pairs are extracted to distinguish different background information for the same drug from different diseases. Finally, a model combining Graph neural network with global Average pooling (GnnAp) is designed to predict potential drug–disease associations by learning drug–disease interaction feature representations. The experimental results show that adding subgraph extraction can effectively improve the prediction performance of the model, and the graph representation learning module can fully extract the deep features of drug–disease. Using the 5-fold cross-validation, the proposed model (GCNGAT) achieves AUC (Area Under the receiver operating characteristic Curve) values of 0.9182 and 0.9417 on the PREDICT dataset and CDataset dataset, respectively. Compared with other predictors on the same dataset (PREDICT dataset), GCNGAT outperforms the existing best-performing model (PSGCN), with a 1.58% increase in the AUC value. It is anticipated that this model can provide experimental reference for drug repositioning and further promote the drug research and development process.

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

MGRL: Predicting Drug-Disease Associations Based on Multi-Graph Representation Learning

Multi-level Subgraph Representation Learning for Drug-Disease Association Prediction over Heterogeneous Biological Information Network.

A Highly Efficient Biomolecular Network Representation Model for Predicting Drug-Disease Associations.

A new framework for drug-disease association prediction combing light-gated message passing neural network and gated fusion mechanism

Attention-based Cross Domain Graph Neural Network for Prediction of Drug-Drug Interactions.

Gndd: A Graph Neural Network-Based Method For Drug-Disease Association Prediction

A Multi-graph Deep Learning Model for Predicting Drug-Disease Associations.

GCNGAT: Drug–disease association prediction based on graph convolution neural network and graph attention network

REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction

Predicting Drug-Disease Associations Through Similarity Network Fusion and Multi-View Feature Projection Representation.

Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network

Drug–disease Associations Prediction Via Multiple Kernel-based Dual Graph Regularized Least Squares

Graph-Based Neural Collaborative Filtering Model for Drug-Disease Associations Prediction

WGMFDDA: A Novel Weighted-Based Graph Regularized Matrix Factorization for Predicting Drug-Disease Associations.

A Graph Representation Approach Based on Light Gradient Boosting Machine for Predicting Drug-Disease Associations.

Empowering Graph Neural Network-Based Computational Drug Repositioning with Large Language Model-Inferred Knowledge Representation

Drug-disease association prediction using semantic graph and function similarity representation learning over heterogeneous information networks

Predicting Drug-Disease Associations by Self-topological Generalized Matrix Factorization with Neighborhood Constraints

Predicting associations between drugs and G protein-coupled receptors using a multi-graph convolutional network

Learning from low-rank multimodal representations for predicting disease-drug associations